Aligos Therapeutics (ALGS) Share-based Compensation (2019 - 2026)
Aligos Therapeutics (ALGS) reported Share-based Compensation of $1.36 million for Q2 2026, up 17.6% from $1.16 million a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aligos Therapeutics' Share-based Compensation came in at $5.6 million, down 4.5% year-over-year; for FY2025, it was $5.04 million, down 40.3% from FY2024.
- Share-based Compensation has declined for three consecutive years, though with a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $8.45 million in FY2024 (-33.2%), $12.65 million in FY2023 (-13.9%), $14.69 million in FY2022 (+9.2%) and $13.46 million in FY2021 (+352.3%).
- Five-year quarterly Share-based Compensation spans a low of $959,000 in Q1 2025 and a high of $4 million in Q2 2022.
- Year over year, Share-based Compensation gained in two of the last eight quarters, with an average decline of 20.7%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 254.4%); the low point was Q1 2025 (a decline of 63.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.31 million (Q1 2026), $1.46 million (Q4 2025) and $1.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.52 Bn | 1,100.11 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 616.33 Bn | 534.86 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 500.08 Bn | 473.19 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.80 Bn | 321.17 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn | - |
| 7 | Amgen | 234.86 Bn | 190.26 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 189.95 Bn | 164.15 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Aligos Therapeutics | 52.68 Mn | -275.73 Mn | - | 1.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Mar 31, 2026 | 89,000.00 |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 138,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 2.58 Mn |
| Sep 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 3.79 Mn |
| Dec 31, 2021 | 3.65 Mn |
| Sep 30, 2021 | 3.59 Mn |
API Access
Aligos Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();